Skip to main content
Top
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Case report

A metastatic invasive mole arising from iatrogenic uterus perforation

Authors: Yuanming Shen, Xiaoyun Wan, Xing Xie

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

Invasive mole derives from hydatidiform mole, but its pathogenesis remains unknown. Invasive mole arising from iatrogenic uterine perforation has not been reported yet.

Case presentation

A reproductive woman was admitted because she suffered form severe abdominal pain and acute intra-abdominal hemorrhage after suction evacuation due to misdiagnosis as inevitable abortion. The patient underwent hysteroscopy and laparoscopy, by which an iatrogenic uterine perforation and omentum and pelvic peritoneum metastases were confirmed. All lesions were removed and the final pathological diagnosis was metastatic invasive mole. The patient underwent post-operative chemotherapy with methotrexate and presented a good prognosis.

Conclusion

Invasive mole arising form iatrogenic uterine perforation displays an unusual metastatic manner other than general invasive moles. The prevention of uterine perforation should be emphasized during suction evacuation for mole pregnancy.
Literature
1.
go back to reference El-Helw LM, Hancock BW. Treatment of metastatic gestational trophoblastic neoplasia. Lancet Oncol. 2007;8(8):715–24. ReviewCrossRefPubMed El-Helw LM, Hancock BW. Treatment of metastatic gestational trophoblastic neoplasia. Lancet Oncol. 2007;8(8):715–24. ReviewCrossRefPubMed
2.
go back to reference Shih IM. Gestational trophoblastic neoplasia—pathogenesis and potential therapeutic targets. Lancet Oncol. 2007;8(7):642–50.CrossRefPubMed Shih IM. Gestational trophoblastic neoplasia—pathogenesis and potential therapeutic targets. Lancet Oncol. 2007;8(7):642–50.CrossRefPubMed
3.
4.
go back to reference Brown J, Naumann RW, Seckl MJ, Schink J. 15years of progress in gestational trophoblastic disease: scoring, standardization, and salvage. Gynecol Oncol. 2017;144(1):200–7.CrossRefPubMed Brown J, Naumann RW, Seckl MJ, Schink J. 15years of progress in gestational trophoblastic disease: scoring, standardization, and salvage. Gynecol Oncol. 2017;144(1):200–7.CrossRefPubMed
5.
go back to reference Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C, ESMO Guidelines Working Group. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi39–50.CrossRefPubMed Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C, ESMO Guidelines Working Group. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi39–50.CrossRefPubMed
6.
go back to reference Candelier JJ. The hydatidiform mole. Cell Adhes Migr. 2016;10(1–2):226–35.CrossRef Candelier JJ. The hydatidiform mole. Cell Adhes Migr. 2016;10(1–2):226–35.CrossRef
7.
go back to reference Alifrangis C, Seckl MJ. Genetics of gestational trophoblastic neoplasia: an update for the clinician. Future Oncol. 2010;6(12):1915–23.CrossRefPubMed Alifrangis C, Seckl MJ. Genetics of gestational trophoblastic neoplasia: an update for the clinician. Future Oncol. 2010;6(12):1915–23.CrossRefPubMed
Metadata
Title
A metastatic invasive mole arising from iatrogenic uterus perforation
Authors
Yuanming Shen
Xiaoyun Wan
Xing Xie
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3904-2

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine